Sampson; John H.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sampson; John H..The latest application filed is for "tetanus toxoid and ccl3 improve dc vaccines".
Company Profile
8.22.28
- Sampson; John H. - Durham NC
- Sampson; John H - Durham NC
- Sampson; John H. - Raleigh NC
Patent Activity
| Patent | Date |
|---|---|
| Oncolytic poliovirus for human tumors Grant 11,406,677 - Gromeier , et al. August 9, 2 | 2022-08-09 |
| Compositions, methods and kits for eliciting an immune response Grant 11,389,530 - Sampson , et al. July 19, 2 | 2022-07-19 |
| Compositions, methods and kits for eliciting an immune response Grant 11,376,322 - Sampson , et al. July 5, 2 | 2022-07-05 |
| Compositions, methods and kits for eliciting an immune response Grant 11,364,295 - Sampson , et al. June 21, 2 | 2022-06-21 |
| Compositions, methods and kits for eliciting an immune response Grant 11,351,248 - Sampson , et al. June 7, 2 | 2022-06-07 |
| Tetanus Toxoid And Ccl3 Improve Dc Vaccines App 20220031827 - Sampson; John H ; et al. | 2022-02-03 |
| Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues App 20210309750 - Sampson; John H. ; et al. | 2021-10-07 |
| Tetanus toxoid and CCL3 improve DC vaccines Grant 11,071,777 - Sampson , et al. July 27, 2 | 2021-07-27 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20210000943 - Sampson; John H. ; et al. | 2021-01-07 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20210000944 - Sampson; John H ; et al. | 2021-01-07 |
| Oncolytic Poliovirus for Human Tumors App 20200405795 - Gromeier; Matthias ; et al. | 2020-12-31 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20200345837 - Sampson; John H. ; et al. | 2020-11-05 |
| Oncolytic poliovirus for human tumors Grant 10,799,543 - Gromeier , et al. October 13, 2 | 2020-10-13 |
| Sequential anti-cancer treatment Grant 10,744,171 - Bigner , et al. A | 2020-08-18 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20200246452 - Kind Code | 2020-08-06 |
| Compositions, methods and kits for eliciting an immune response Grant 10,632,190 - Sampson , et al. | 2020-04-28 |
| Oncolytic Poliovirus for Human Tumors App 20190343904 - Gromeier; Matthias ; et al. | 2019-11-14 |
| Oncolytic poliovirus for human tumors Grant 10,398,743 - Gromeier , et al. Sep | 2019-09-03 |
| Sequential Anti-Cancer Treatment App 20190105360 - Bigner; Darell D. ; et al. | 2019-04-11 |
| Tetanus Toxoid and CCL3 Improve DC Vaccines App 20180236054 - Sampson; John H. ; et al. | 2018-08-23 |
| Concurrent Chemotherapy and Immunotherapy App 20180215789 - Sampson; John H. ; et al. | 2018-08-02 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20180153982 - Sampson; John H. ; et al. | 2018-06-07 |
| Tetanus toxoid and CCL3 improve DC vaccines Grant 9,974,848 - Sampson , et al. May 22, 2 | 2018-05-22 |
| Compositions, methods and kits for eliciting an immune response Grant 9,950,056 - Sampson , et al. April 24, 2 | 2018-04-24 |
| Compositions, methods, and kits for eliciting an immune response Grant 9,764,026 - Sampson , et al. September 19, 2 | 2017-09-19 |
| Oncolytic Poliovirus for Human Tumors App 20170216382 - Gromeier; Matthias ; et al. | 2017-08-03 |
| Tetanus Toxoid and CCL3 Improve DC Vaccines App 20160271240 - Sampson; John H. ; et al. | 2016-09-22 |
| Compositions, Methods And Kits For Eliciting An Immune Response App 20160213771 - Sampson; John H. ; et al. | 2016-07-28 |
| Concurrent chemotherapy and immunotherapy Grant 9,399,662 - Sampson , et al. July 26, 2 | 2016-07-26 |
| Oncolytic Poliovirus For Human Tumors App 20160030497 - GROMEIER; Matthias ; et al. | 2016-02-04 |
| Bispecific EGFRvIII x CD3 antibody engaging molecules Grant 9,249,217 - Bigner , et al. February 2, 2 | 2016-02-02 |
| Compositions, Methods, And Kits For Eliciting An Immune Response App 20150335732 - Sampson; John H. ; et al. | 2015-11-26 |
| Enhanced immunological responses App 20150307614 - Sampson; John H. ; et al. | 2015-10-29 |
| Concurrent Chemotherapy and Immunotherapy App 20150118181 - Sampson; John H. ; et al. | 2015-04-30 |
| Compositions, methods, and kits for eliciting an immune response Grant 9,011,835 - Sampson , et al. April 21, 2 | 2015-04-21 |
| Assay for anti-EGFRvIII antibodies Grant 8,900,816 - Schmittling , et al. December 2, 2 | 2014-12-02 |
| Compositions, Methods, And Kits For Eliciting An Immune Response App 20130189224 - Sampson; John H. ; et al. | 2013-07-25 |
| Compositions, methods, and kits for eliciting an immune response Grant 8,425,898 - Sampson , et al. April 23, 2 | 2013-04-23 |
| Compositions, Methods, And Kits For Eliciting An Immune Response App 20120288473 - Sampson; John H. ; et al. | 2012-11-15 |
| Enhanced Immunological Responses App 20120244145 - Sampson; John H. ; et al. | 2012-09-27 |
| BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES App 20120189630 - BIGNER; Darell D. ; et al. | 2012-07-26 |
| ASSAY FOR ANTI-EGFRvIII ANTIBODIES App 20120115739 - Schmittling; Robert J. ; et al. | 2012-05-10 |
| Composition And Methods For Eliciting An Immune Response App 20110236345 - Sampson; John H. ; et al. | 2011-09-29 |
| Trimodal Cancer Therapy App 20110135637 - Sampson; John H. ; et al. | 2011-06-09 |
| Concurrent Chemotherapy And Immunotherapy App 20090220551 - Sampson; John H. ; et al. | 2009-09-03 |
Company Registrations
| NCAGE Code | 45U37 | SAMPSON JOHN H |
| CAGE Code | 45U37 | SAMPSON, JOHN H |
| DUNS | 606008030 | SAMPSON, JOHN H |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 